<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;ff=20240729204408&amp;fc=20230708114047
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;ff=20240729204408&amp;fc=20230708114047" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Tue, 30 Jul 2024 00:44:10 +0000</lastbuilddate>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39074185/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 30;150(5):e105. doi: 10.1161/CIR.0000000000001272. Epub 2024 Jul 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39074185/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39074185</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001272>10.1161/CIR.0000000000001272</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39074185</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:date>2024-07-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</dc:title>
<dc:identifier>pmid:39074185</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001272</dc:identifier>
</item>
<item>
<title>IGFBP7: From Senescence Biomarker to a Vaccine for Heart Failure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39074184/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 30;150(5):390-392. doi: 10.1161/CIRCULATIONAHA.124.067059. Epub 2024 Jul 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39074184/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39074184</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.067059>10.1161/CIRCULATIONAHA.124.067059</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39074184</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Joseph Pierre Aboumsallem</dc:creator>
<dc:creator>Rudolf A de Boer</dc:creator>
<dc:date>2024-07-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>IGFBP7: From Senescence Biomarker to a Vaccine for Heart Failure</dc:title>
<dc:identifier>pmid:39074184</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.067059</dc:identifier>
</item>
<item>
<title>Response by Lambiase and van Duijvenboden to Letter Regarding Article, "Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39074183/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 30;150(5):e104. doi: 10.1161/CIRCULATIONAHA.124.069705. Epub 2024 Jul 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39074183/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39074183</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069705>10.1161/CIRCULATIONAHA.124.069705</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39074183</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Pier D Lambiase</dc:creator>
<dc:creator>Stefan van Duijvenboden</dc:creator>
<dc:date>2024-07-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Response by Lambiase and van Duijvenboden to Letter Regarding Article, "Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects"</dc:title>
<dc:identifier>pmid:39074183</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069705</dc:identifier>
</item>
<item>
<title>ECG Challenge: The Eye Sees Only What the Mind Is Prepared to Comprehend</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39074182/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 30;150(5):411-413. doi: 10.1161/CIRCULATIONAHA.124.070453. Epub 2024 Jul 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39074182/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39074182</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070453>10.1161/CIRCULATIONAHA.124.070453</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39074182</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Suresh Kumar Sukumaran</dc:creator>
<dc:creator>Anandaraja Subramanian</dc:creator>
<dc:creator>Raja J Selvaraj</dc:creator>
<dc:date>2024-07-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>ECG Challenge: The Eye Sees Only What the Mind Is Prepared to Comprehend</dc:title>
<dc:identifier>pmid:39074182</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070453</dc:identifier>
</item>
<item>
<title>Letter by Katsouras Regarding Article, "Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39074181/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 30;150(5):e102-e103. doi: 10.1161/CIRCULATIONAHA.124.068557. Epub 2024 Jul 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39074181/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39074181</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.068557>10.1161/CIRCULATIONAHA.124.068557</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39074181</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Christos S Katsouras</dc:creator>
<dc:date>2024-07-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Katsouras Regarding Article, "Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects"</dc:title>
<dc:identifier>pmid:39074181</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.068557</dc:identifier>
</item>
<item>
<title>General Capillary Endothelial Cells Undergo Reprogramming Into Arterial Endothelial Cells in Pulmonary Hypertension Through HIF-2α/Notch4 Pathway</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39074180/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 30;150(5):414-417. doi: 10.1161/CIRCULATIONAHA.123.067981. Epub 2024 Jul 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39074180/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39074180</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067981>10.1161/CIRCULATIONAHA.123.067981</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39074180</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Bin Liu</dc:creator>
<dc:creator>Dan Yi</dc:creator>
<dc:creator>Xiaomei Xia</dc:creator>
<dc:creator>Karina Ramirez</dc:creator>
<dc:creator>Hanqiu Zhao</dc:creator>
<dc:creator>Yanhong Cao</dc:creator>
<dc:creator>Ankit Tripathi</dc:creator>
<dc:creator>Ryan Dong</dc:creator>
<dc:creator>Anton Gao</dc:creator>
<dc:creator>Hongxu Ding</dc:creator>
<dc:creator>Shenfeng Qiu</dc:creator>
<dc:creator>Vladimir V Kalinichenko</dc:creator>
<dc:creator>You-Yang Zhao</dc:creator>
<dc:creator>Michael B Fallon</dc:creator>
<dc:creator>Zhiyu Dai</dc:creator>
<dc:date>2024-07-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>General Capillary Endothelial Cells Undergo Reprogramming Into Arterial Endothelial Cells in Pulmonary Hypertension Through HIF-2α/Notch4 Pathway</dc:title>
<dc:identifier>pmid:39074180</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067981</dc:identifier>
</item>
<item>
<title>Myocardial Regeneration: Feasible or Fantasy?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39074179/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 30;150(5):347-349. doi: 10.1161/CIRCULATIONAHA.124.070136. Epub 2024 Jul 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39074179/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39074179</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070136>10.1161/CIRCULATIONAHA.124.070136</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39074179</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Eric N Olson</dc:creator>
<dc:date>2024-07-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Myocardial Regeneration: Feasible or Fantasy?</dc:title>
<dc:identifier>pmid:39074179</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070136</dc:identifier>
</item>
<item>
<title>Endothelial Dysfunction in Youth-Onset Type 2 Diabetes: A Clinical Translational Study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39069898/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Coronary and brachial endothelial dysfunction was evident in Y-T2D who were within 5 years of diagnosis and did not have severe hyperglycemia or dyslipidemia. Plasma-derived small extracellular vesicles induced markers of endothelial dysfunction, which corroborated accelerated subclinical coronary atherosclerosis as an early feature in Y-T2D.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Jul 29. doi: 10.1161/CIRCRESAHA.124.324272. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Youth-onset type 2 diabetes (Y-T2D) is associated with increased risk for coronary atherosclerotic disease, but the timing of the earliest pathological features and evidence of cardiac endothelial dysfunction have not been evaluated in this population. Magnetic resonance imaging functional imaging may detect early and direct endothelial dysfunction in the absence of classical risk factors (severe hyperglycemia, hypertension, and hyperlipidemia). Using cardiac magnetic resonance imaging functional imaging, we evaluated peripheral and coronary endothelial artery structure and function in young adults with Y-T2D diagnosed ≤5 years compared with age-matched healthy peers. We isolated and characterized plasma-derived small extracellular vesicles and evaluated their effects on inflammatory and signaling biomarkers in healthy human coronary artery endothelial cells to validate the imaging findings.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Right coronary wall thickness, coronary artery flow-mediated dilation, and brachial artery flow-mediated dilation were measured at baseline and during isometric handgrip exercise using a 3.0T magnetic resonance imaging. Human coronary artery endothelial cells were treated with Y-T2D plasma-derived small extracellular vesicles. Protein expression was measured by Western blot analysis, oxidative stress was measured using the redox-sensitive probe dihydroethidium, and nitric oxide levels were measured by 4-amino-5-methylamino-2',7'-difluororescein diacetate.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Y-T2D (n=20) had higher hemoglobin A1c and high-sensitivity C-reactive protein, but similar total and LDL (low-density lipoprotein)-cholesterol compared with healthy peers (n=16). Y-T2D had greater coronary wall thickness (1.33±0.13 versus 1.22±0.13 mm; <i>P</i>=0.04) and impaired endothelial function: coronary artery flow-mediated dilation (-3.1±15.5 versus 15.9±17.3%; <i>P</i>&lt;0.01) and brachial artery flow-mediated dilation (6.7±14.7 versus 26.4±15.2%; <i>P</i>=0.001). Y-T2D plasma-derived small extracellular vesicles reduced phosphorylated endothelial nitric oxide synthase expression and nitric oxide levels, increased reactive oxygen species production, and elevated ICAM (intercellular adhesion molecule)-mediated inflammatory pathways in human coronary artery endothelial cells.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Coronary and brachial endothelial dysfunction was evident in Y-T2D who were within 5 years of diagnosis and did not have severe hyperglycemia or dyslipidemia. Plasma-derived small extracellular vesicles induced markers of endothelial dysfunction, which corroborated accelerated subclinical coronary atherosclerosis as an early feature in Y-T2D.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02830308.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39069898/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39069898</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.324272>10.1161/CIRCRESAHA.124.324272</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39069898</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Khalid Zabd-Elmoniem</dc:creator>
<dc:creator>Jehad Edwan</dc:creator>
<dc:creator>Katrina B Dietsche</dc:creator>
<dc:creator>Alfredo Villalobos-Perez</dc:creator>
<dc:creator>Nour Shams</dc:creator>
<dc:creator>Jatin Matta</dc:creator>
<dc:creator>Leilah Baumgarten</dc:creator>
<dc:creator>Waleed N Qaddumi</dc:creator>
<dc:creator>Sydney A Dixon</dc:creator>
<dc:creator>Aruba Chowdhury</dc:creator>
<dc:creator>Michael Stagliano</dc:creator>
<dc:creator>Lilian Mabundo</dc:creator>
<dc:creator>Annemarie Wentzel</dc:creator>
<dc:creator>Colleen Hadigan</dc:creator>
<dc:creator>Ahmed M Gharib</dc:creator>
<dc:creator>Stephanie T Chung</dc:creator>
<dc:date>2024-07-29</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Endothelial Dysfunction in Youth-Onset Type 2 Diabetes: A Clinical Translational Study</dc:title>
<dc:identifier>pmid:39069898</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.324272</dc:identifier>
</item>
<item>
<title>Extensive structural rearrangement of intraflagellar transport trains underpins bidirectional cargo transport</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39067443/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>Bidirectional transport in cilia is carried out by polymers of the IFTA and IFTB protein complexes, called anterograde and retrograde intraflagellar transport (IFT) trains. Anterograde trains deliver cargoes from the cell to the cilium tip, then convert into retrograde trains for cargo export. We set out to understand how the IFT complexes can perform these two directly opposing roles before and after conversion. We use cryoelectron tomography and in situ cross-linking mass spectrometry to...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 23:S0092-8674(24)00715-3. doi: 10.1016/j.cell.2024.06.041. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Bidirectional transport in cilia is carried out by polymers of the IFTA and IFTB protein complexes, called anterograde and retrograde intraflagellar transport (IFT) trains. Anterograde trains deliver cargoes from the cell to the cilium tip, then convert into retrograde trains for cargo export. We set out to understand how the IFT complexes can perform these two directly opposing roles before and after conversion. We use cryoelectron tomography and in situ cross-linking mass spectrometry to determine the structure of retrograde IFT trains and compare it with the known structure of anterograde trains. The retrograde train is a 2-fold symmetric polymer organized around a central thread of IFTA complexes. We conclude that anterograde-to-retrograde remodeling involves global rearrangements of the IFTA/B complexes and requires complete disassembly of the anterograde train. Finally, we describe how conformational changes to cargo-binding sites facilitate unidirectional cargo transport in a bidirectional system.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39067443/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39067443</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.041>10.1016/j.cell.2024.06.041</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39067443</guid>
<pubDate>Sat, 27 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Samuel E Lacey</dc:creator>
<dc:creator>Andrea Graziadei</dc:creator>
<dc:creator>Gaia Pigino</dc:creator>
<dc:date>2024-07-27</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Extensive structural rearrangement of intraflagellar transport trains underpins bidirectional cargo transport</dc:title>
<dc:identifier>pmid:39067443</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.041</dc:identifier>
</item>
<item>
<title>Translational potential of mouse models of human metabolic disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39067442/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>Obesity causes significant morbidity and mortality globally. Research in the last three decades has delivered a step-change in our understanding of the fundamental mechanisms that regulate energy homeostasis, building on foundational discoveries in mouse models of metabolic disease. However, not all findings made in rodents have translated to humans, hampering drug discovery in this field. Here, we review how studies in mice and humans have informed our current framework for understanding energy...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 24:S0092-8674(24)00771-2. doi: 10.1016/j.cell.2024.07.011. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Obesity causes significant morbidity and mortality globally. Research in the last three decades has delivered a step-change in our understanding of the fundamental mechanisms that regulate energy homeostasis, building on foundational discoveries in mouse models of metabolic disease. However, not all findings made in rodents have translated to humans, hampering drug discovery in this field. Here, we review how studies in mice and humans have informed our current framework for understanding energy homeostasis, discuss their challenges and limitations, and offer a perspective on how human studies may play an increasingly important role in the discovery of disease mechanisms and identification of therapeutic targets in the future.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39067442/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39067442</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.07.011>10.1016/j.cell.2024.07.011</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39067442</guid>
<pubDate>Sat, 27 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>I Sadaf Farooqi</dc:creator>
<dc:creator>Yong Xu</dc:creator>
<dc:date>2024-07-27</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Translational potential of mouse models of human metabolic disease</dc:title>
<dc:identifier>pmid:39067442</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.07.011</dc:identifier>
</item>
<item>
<title>Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059381/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>Plasmodium falciparum reticulocyte-binding protein homolog 5 (RH5) is the most advanced blood-stage malaria vaccine candidate and is being evaluated for efficacy in endemic regions, emphasizing the need to study the underlying antibody response to RH5 during natural infection, which could augment or counteract responses to vaccination. Here, we found that RH5-reactive B cells were rare, and circulating immunoglobulin G (IgG) responses to RH5 were short-lived in malaria-exposed Malian...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 17:S0092-8674(24)00711-6. doi: 10.1016/j.cell.2024.06.037. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Plasmodium falciparum reticulocyte-binding protein homolog 5 (RH5) is the most advanced blood-stage malaria vaccine candidate and is being evaluated for efficacy in endemic regions, emphasizing the need to study the underlying antibody response to RH5 during natural infection, which could augment or counteract responses to vaccination. Here, we found that RH5-reactive B cells were rare, and circulating immunoglobulin G (IgG) responses to RH5 were short-lived in malaria-exposed Malian individuals, despite repeated infections over multiple years. RH5-specific monoclonal antibodies isolated from eight malaria-exposed individuals mostly targeted non-neutralizing epitopes, in contrast to antibodies isolated from five RH5-vaccinated, malaria-naive UK individuals. However, MAD8-151 and MAD8-502, isolated from two malaria-exposed Malian individuals, were among the most potent neutralizers out of 186 antibodies from both cohorts and targeted the same epitopes as the most potent vaccine-induced antibodies. These results suggest that natural malaria infection may boost RH5-vaccine-induced responses and provide a clear strategy for the development of next-generation RH5 vaccines.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059381/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39059381</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.037>10.1016/j.cell.2024.06.037</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059381</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Lawrence T Wang</dc:creator>
<dc:creator>Andrew J R Cooper</dc:creator>
<dc:creator>Brendan Farrell</dc:creator>
<dc:creator>Kazutoyo Miura</dc:creator>
<dc:creator>Ababacar Diouf</dc:creator>
<dc:creator>Nicole Müller-Sienerth</dc:creator>
<dc:creator>Cécile Crosnier</dc:creator>
<dc:creator>Lauren Purser</dc:creator>
<dc:creator>Payton J Kirtley</dc:creator>
<dc:creator>Maciej Maciuszek</dc:creator>
<dc:creator>Jordan R Barrett</dc:creator>
<dc:creator>Kirsty McHugh</dc:creator>
<dc:creator>Rodney Ogwang</dc:creator>
<dc:creator>Courtney Tucker</dc:creator>
<dc:creator>Shanping Li</dc:creator>
<dc:creator>Safiatou Doumbo</dc:creator>
<dc:creator>Didier Doumtabe</dc:creator>
<dc:creator>Chul-Woo Pyo</dc:creator>
<dc:creator>Jeff Skinner</dc:creator>
<dc:creator>Carolyn M Nielsen</dc:creator>
<dc:creator>Sarah E Silk</dc:creator>
<dc:creator>Kassoum Kayentao</dc:creator>
<dc:creator>Aissata Ongoiba</dc:creator>
<dc:creator>Ming Zhao</dc:creator>
<dc:creator>Doan C Nguyen</dc:creator>
<dc:creator>F Eun-Hyung Lee</dc:creator>
<dc:creator>Angela M Minassian</dc:creator>
<dc:creator>Daniel E Geraghty</dc:creator>
<dc:creator>Boubacar Traore</dc:creator>
<dc:creator>Robert A Seder</dc:creator>
<dc:creator>Brandon K Wilder</dc:creator>
<dc:creator>Peter D Crompton</dc:creator>
<dc:creator>Gavin J Wright</dc:creator>
<dc:creator>Carole A Long</dc:creator>
<dc:creator>Simon J Draper</dc:creator>
<dc:creator>Matthew K Higgins</dc:creator>
<dc:creator>Joshua Tan</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5</dc:title>
<dc:identifier>pmid:39059381</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.037</dc:identifier>
</item>
<item>
<title>Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059380/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>The highly conserved and essential Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) has emerged as the leading target for vaccines against the disease-causing blood stage of malaria. However, the features of the human vaccine-induced antibody response that confer highly potent inhibition of malaria parasite invasion into red blood cells are not well defined. Here, we characterize 236 human IgG monoclonal antibodies, derived from 15 donors, induced by the most advanced PfRH5...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 18:S0092-8674(24)00655-X. doi: 10.1016/j.cell.2024.06.015. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The highly conserved and essential Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) has emerged as the leading target for vaccines against the disease-causing blood stage of malaria. However, the features of the human vaccine-induced antibody response that confer highly potent inhibition of malaria parasite invasion into red blood cells are not well defined. Here, we characterize 236 human IgG monoclonal antibodies, derived from 15 donors, induced by the most advanced PfRH5 vaccine. We define the antigenic landscape of this molecule and establish that epitope specificity, antibody association rate, and intra-PfRH5 antibody interactions are key determinants of functional anti-parasitic potency. In addition, we identify a germline IgG gene combination that results in an exceptionally potent class of antibody and demonstrate its prophylactic potential to protect against P. falciparum parasite challenge in vivo. This comprehensive dataset provides a framework to guide rational design of next-generation vaccines and prophylactic antibodies to protect against blood-stage malaria.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059380/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39059380</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.015>10.1016/j.cell.2024.06.015</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059380</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Jordan R Barrett</dc:creator>
<dc:creator>Dimitra Pipini</dc:creator>
<dc:creator>Nathan D Wright</dc:creator>
<dc:creator>Andrew J R Cooper</dc:creator>
<dc:creator>Giacomo Gorini</dc:creator>
<dc:creator>Doris Quinkert</dc:creator>
<dc:creator>Amelia M Lias</dc:creator>
<dc:creator>Hannah Davies</dc:creator>
<dc:creator>Cassandra A Rigby</dc:creator>
<dc:creator>Maya Aleshnick</dc:creator>
<dc:creator>Barnabas G Williams</dc:creator>
<dc:creator>William J Bradshaw</dc:creator>
<dc:creator>Neil G Paterson</dc:creator>
<dc:creator>Thomas Martinson</dc:creator>
<dc:creator>Payton Kirtley</dc:creator>
<dc:creator>Luc Picard</dc:creator>
<dc:creator>Christine D Wiggins</dc:creator>
<dc:creator>Francesca R Donnellan</dc:creator>
<dc:creator>Lloyd D W King</dc:creator>
<dc:creator>Lawrence T Wang</dc:creator>
<dc:creator>Jonathan F Popplewell</dc:creator>
<dc:creator>Sarah E Silk</dc:creator>
<dc:creator>Jed de Ruiter Swain</dc:creator>
<dc:creator>Katherine Skinner</dc:creator>
<dc:creator>Vinayaka Kotraiah</dc:creator>
<dc:creator>Amy R Noe</dc:creator>
<dc:creator>Randall S MacGill</dc:creator>
<dc:creator>C Richter King</dc:creator>
<dc:creator>Ashley J Birkett</dc:creator>
<dc:creator>Lorraine A Soisson</dc:creator>
<dc:creator>Angela M Minassian</dc:creator>
<dc:creator>Douglas A Lauffenburger</dc:creator>
<dc:creator>Kazutoyo Miura</dc:creator>
<dc:creator>Carole A Long</dc:creator>
<dc:creator>Brandon K Wilder</dc:creator>
<dc:creator>Lizbé Koekemoer</dc:creator>
<dc:creator>Joshua Tan</dc:creator>
<dc:creator>Carolyn M Nielsen</dc:creator>
<dc:creator>Kirsty McHugh</dc:creator>
<dc:creator>Simon J Draper</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype</dc:title>
<dc:identifier>pmid:39059380</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.015</dc:identifier>
</item>
<item>
<title>"Boosting" tumor immunity in elderly mice by hyperactivating dendritic cells</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059365/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>Immunosenescence poses a significant challenge to tumor immunotherapy in elderly individuals. In this issue of Cell, Zhivaki et al. elucidate that dendritic cells "hyperactivated" by specific adjuvants elicit T(H)1-skewed CD4^(+) T cell responses in a manner contingent on the NLRP3 inflammasome, which can eliminate tumors in aged mice.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 25;187(15):3885-3887. doi: 10.1016/j.cell.2024.06.025.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Immunosenescence poses a significant challenge to tumor immunotherapy in elderly individuals. In this issue of Cell, Zhivaki et al. elucidate that dendritic cells "hyperactivated" by specific adjuvants elicit T<sub>H</sub>1-skewed CD4<sup>+</sup> T cell responses in a manner contingent on the NLRP3 inflammasome, which can eliminate tumors in aged mice.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059365/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39059365</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.025>10.1016/j.cell.2024.06.025</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059365</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Jiaqi Liu</dc:creator>
<dc:creator>Feng Shao</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>"Boosting" tumor immunity in elderly mice by hyperactivating dendritic cells</dc:title>
<dc:identifier>pmid:39059365</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.025</dc:identifier>
</item>
<item>
<title>Translating metabolic and cardiovascular research into effective treatments: What's next?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059364/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>The future of healthcare for cardiovascular diseases holds immense promise, not only based in new discoveries in cardiac metabolism but also in translating them to solutions for critical challenges faced by society. Here, ten scientists share their insights, shedding light on the future that lies ahead for this field.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 25;187(15):3880-3884. doi: 10.1016/j.cell.2024.06.034.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The future of healthcare for cardiovascular diseases holds immense promise, not only based in new discoveries in cardiac metabolism but also in translating them to solutions for critical challenges faced by society. Here, ten scientists share their insights, shedding light on the future that lies ahead for this field.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059364/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39059364</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.034>10.1016/j.cell.2024.06.034</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059364</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Juleen R Zierath</dc:creator>
<dc:creator>Jolanda van der Velden</dc:creator>
<dc:creator>Ali Javaheri</dc:creator>
<dc:creator>Anthony Rosenzweig</dc:creator>
<dc:creator>Deborah M Muoio</dc:creator>
<dc:creator>Erin E Mulvihill</dc:creator>
<dc:creator>Tami A Martino</dc:creator>
<dc:creator>Adil Rasheed</dc:creator>
<dc:creator>Xiao-Wei Chen</dc:creator>
<dc:creator>Zoltan P Arany</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Translating metabolic and cardiovascular research into effective treatments: What's next?</dc:title>
<dc:identifier>pmid:39059364</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.034</dc:identifier>
</item>
<item>
<title>Metabolism in the spotlight: Dr. Giles Yeo on the impact and challenges of science communication</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059363/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>In this interview with Cell, Dr. Giles Yeo shares his journey into metabolism research, his strategies for engaging audiences, and the challenges of simplifying complex concepts. He also discusses the impact of social media, the advantages of podcasting, and the question he's most afraid of.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 25;187(15):3877-3879. doi: 10.1016/j.cell.2024.05.049.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">In this interview with Cell, Dr. Giles Yeo shares his journey into metabolism research, his strategies for engaging audiences, and the challenges of simplifying complex concepts. He also discusses the impact of social media, the advantages of podcasting, and the question he's most afraid of.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059363/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39059363</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.05.049>10.1016/j.cell.2024.05.049</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059363</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Giles S H Yeo</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Metabolism in the spotlight: Dr. Giles Yeo on the impact and challenges of science communication</dc:title>
<dc:identifier>pmid:39059363</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.05.049</dc:identifier>
</item>
<item>
<title>Digesting the complex metabolic effects of diet on the host and microbiome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059362/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>The past 50 years of interdisciplinary research in humans and model organisms has delivered unprecedented insights into the mechanisms through which diet affects energy balance. However, translating these results to prevent and treat obesity and its associated diseases remains challenging. Given the vast scope of this literature, we focus this Review on recent conceptual advances in molecular nutrition targeting the management of energy balance, including emerging dietary and pharmaceutical...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 25;187(15):3857-3876. doi: 10.1016/j.cell.2024.06.032.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The past 50 years of interdisciplinary research in humans and model organisms has delivered unprecedented insights into the mechanisms through which diet affects energy balance. However, translating these results to prevent and treat obesity and its associated diseases remains challenging. Given the vast scope of this literature, we focus this Review on recent conceptual advances in molecular nutrition targeting the management of energy balance, including emerging dietary and pharmaceutical interventions and their interactions with the human gut microbiome. Notably, multiple current dietary patterns of interest embrace moderate-to-high fat intake or prioritize the timing of eating over macronutrient intake. Furthermore, the rapid expansion of microbiome research findings has complicated multiple longstanding tenets of nutrition while also providing new opportunities for intervention. Continued progress promises more precise and reliable dietary recommendations that leverage our growing knowledge of the microbiome, the changing landscape of clinical interventions, and our molecular understanding of human biology.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059362/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39059362</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.032>10.1016/j.cell.2024.06.032</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059362</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Rachel N Carmody</dc:creator>
<dc:creator>Krista Varady</dc:creator>
<dc:creator>Peter J Turnbaugh</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Digesting the complex metabolic effects of diet on the host and microbiome</dc:title>
<dc:identifier>pmid:39059362</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.032</dc:identifier>
</item>
<item>
<title>A metabolic balance of GLP-1 and NMDA receptors in the brain</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059361/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>Glucagon-like peptide-1 (GLP-1) and N-methyl-D-aspartate (NMDA) receptors in the brain regulate metabolic homeostasis. In a paper published in Nature, Petersen et al. describe a bimodal molecule that conjugates a GLP-1 analog with MK-801 (NMDA receptor antagonist), which lowers feeding and body weight to a greater extent than the GLP-1R agonist alone.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 25;187(15):3854-3856. doi: 10.1016/j.cell.2024.06.031.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Glucagon-like peptide-1 (GLP-1) and N-methyl-D-aspartate (NMDA) receptors in the brain regulate metabolic homeostasis. In a paper published in Nature, Petersen et al. describe a bimodal molecule that conjugates a GLP-1 analog with MK-801 (NMDA receptor antagonist), which lowers feeding and body weight to a greater extent than the GLP-1R agonist alone.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059361/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39059361</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.031>10.1016/j.cell.2024.06.031</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059361</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Jessica T Y Yue</dc:creator>
<dc:creator>Ameth N Garrido</dc:creator>
<dc:creator>Tony K T Lam</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A metabolic balance of GLP-1 and NMDA receptors in the brain</dc:title>
<dc:identifier>pmid:39059361</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.031</dc:identifier>
</item>
<item>
<title>Transforming obesity: The advancement of multi-receptor drugs</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059360/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>For more than a century, physicians have searched for ways to pharmacologically reduce excess body fat. The tide has finally turned with recent advances in biochemically engineered agonists for the receptor of glucagon-like peptide-1 (GLP-1) and their use in GLP-1-based polyagonists. These polyagonists reduce body weight through complementary pharmacology by incorporating the receptors for glucagon and/or the glucose-dependent insulinotropic polypeptide (GIP). In their most advanced forms,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 25;187(15):3829-3853. doi: 10.1016/j.cell.2024.06.003.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">For more than a century, physicians have searched for ways to pharmacologically reduce excess body fat. The tide has finally turned with recent advances in biochemically engineered agonists for the receptor of glucagon-like peptide-1 (GLP-1) and their use in GLP-1-based polyagonists. These polyagonists reduce body weight through complementary pharmacology by incorporating the receptors for glucagon and/or the glucose-dependent insulinotropic polypeptide (GIP). In their most advanced forms, gut-hormone polyagonists achieve an unprecedented weight reduction of up to ∼20%-30%, offering a pharmacological alternative to bariatric surgery. Along with favorable effects on glycemia, fatty liver, and kidney disease, they also offer beneficial effects on the cardiovascular system and adipose tissue. These new interventions, therefore, hold great promise for the future of anti-obesity medications.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059360/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39059360</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.003>10.1016/j.cell.2024.06.003</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059360</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Christine M Kusminski</dc:creator>
<dc:creator>Diego Perez-Tilve</dc:creator>
<dc:creator>Timo D Müller</dc:creator>
<dc:creator>Richard D DiMarchi</dc:creator>
<dc:creator>Matthias H Tschöp</dc:creator>
<dc:creator>Philipp E Scherer</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Transforming obesity: The advancement of multi-receptor drugs</dc:title>
<dc:identifier>pmid:39059360</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.003</dc:identifier>
</item>
<item>
<title>100 years of the Warburg effect: A cancer metabolism endeavor</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059359/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>If you are a scientist and you only know one thing about tumor metabolism, it's likely the Warburg effect. But who was Otto Warburg, and how did his discoveries regarding the metabolism of tumors shape our current thinking about the metabolic needs of cancer cells?</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 25;187(15):3824-3828. doi: 10.1016/j.cell.2024.06.026.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">If you are a scientist and you only know one thing about tumor metabolism, it's likely the Warburg effect. But who was Otto Warburg, and how did his discoveries regarding the metabolism of tumors shape our current thinking about the metabolic needs of cancer cells?</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059359/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39059359</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.026>10.1016/j.cell.2024.06.026</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059359</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Sarah-Maria Fendt</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>100 years of the Warburg effect: A cancer metabolism endeavor</dc:title>
<dc:identifier>pmid:39059359</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.026</dc:identifier>
</item>
<item>
<title>Metabolic heterogeneity in humans</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059358/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>Recent advancements in technology, especially the emergence of single-cell technologies, genomic sequencing, metabolomics, and artificial intelligence, have enabled us to understand the distinct metabolic changes in different cell types, tissues, genders, disease states, ages, and populations. Six scientists whose work intersects with metabolism in various capacities tell us about their vision for human metabolic heterogeneity.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 25;187(15):3821-3823. doi: 10.1016/j.cell.2024.06.033.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Recent advancements in technology, especially the emergence of single-cell technologies, genomic sequencing, metabolomics, and artificial intelligence, have enabled us to understand the distinct metabolic changes in different cell types, tissues, genders, disease states, ages, and populations. Six scientists whose work intersects with metabolism in various capacities tell us about their vision for human metabolic heterogeneity.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059358/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39059358</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.033>10.1016/j.cell.2024.06.033</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059358</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Heather Christofk</dc:creator>
<dc:creator>Christian Metallo</dc:creator>
<dc:creator>Guanghui Liu</dc:creator>
<dc:creator>Joshua Rabinowitz</dc:creator>
<dc:creator>Lauren Sparks</dc:creator>
<dc:creator>David James</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Metabolic heterogeneity in humans</dc:title>
<dc:identifier>pmid:39059358</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.033</dc:identifier>
</item>
<item>
<title>Diabetes mellitus-Progress and opportunities in the evolving epidemic</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059357/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240729204408&amp;v=2.18.0.post9+e462414
      <description>Diabetes, a complex multisystem metabolic disorder characterized by hyperglycemia, leads to complications that reduce quality of life and increase mortality. Diabetes pathophysiology includes dysfunction of beta cells, adipose tissue, skeletal muscle, and liver. Type 1 diabetes (T1D) results from immune-mediated beta cell destruction. The more prevalent type 2 diabetes (T2D) is a heterogeneous disorder characterized by varying degrees of beta cell dysfunction in concert with insulin resistance....</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 25;187(15):3789-3820. doi: 10.1016/j.cell.2024.06.029.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Diabetes, a complex multisystem metabolic disorder characterized by hyperglycemia, leads to complications that reduce quality of life and increase mortality. Diabetes pathophysiology includes dysfunction of beta cells, adipose tissue, skeletal muscle, and liver. Type 1 diabetes (T1D) results from immune-mediated beta cell destruction. The more prevalent type 2 diabetes (T2D) is a heterogeneous disorder characterized by varying degrees of beta cell dysfunction in concert with insulin resistance. The strong association between obesity and T2D involves pathways regulated by the central nervous system governing food intake and energy expenditure, integrating inputs from peripheral organs and the environment. The risk of developing diabetes or its complications represents interactions between genetic susceptibility and environmental factors, including the availability of nutritious food and other social determinants of health. This perspective reviews recent advances in understanding the pathophysiology and treatment of diabetes and its complications, which could alter the course of this prevalent disorder.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059357/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240729204408&v=2.18.0.post9+e462414">39059357</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.029>10.1016/j.cell.2024.06.029</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059357</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>E Dale Abel</dc:creator>
<dc:creator>Anna L Gloyn</dc:creator>
<dc:creator>Carmella Evans-Molina</dc:creator>
<dc:creator>Joshua J Joseph</dc:creator>
<dc:creator>Shivani Misra</dc:creator>
<dc:creator>Utpal B Pajvani</dc:creator>
<dc:creator>Judith Simcox</dc:creator>
<dc:creator>Katalin Susztak</dc:creator>
<dc:creator>Daniel J Drucker</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Diabetes mellitus-Progress and opportunities in the evolving epidemic</dc:title>
<dc:identifier>pmid:39059357</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.029</dc:identifier>
</item>





























</channel>
</rss>